Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) vs Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
Side-by-side comparison of two grants.
| Attribute | Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) | Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | $250K | — |
| Deadline | Closes 2026-10-14 | Closes 2027-07-17 |
| Region | US | US |
| Sector | Education | Education |
| Funder | National Institutes of Health | National Institutes of Health |
| Who it's for | nonprofits, researchers, government | researchers, students, government |